Oncolytics Biotech Inc.

499 articles with Oncolytics Biotech Inc.

• Oncolytics Biotech Inc.'s Research Collaborators To Present REOLYSIN(R) Clinical Trial Data At American Society of Clinical Oncology Conference

  3/16/2006

• Oncolytics Biotech Inc. To Present At Invest Northwest CEO And Investor Conference

  3/16/2006

• Oncolytics Biotech Inc. Reports Highlights And Financial Results For 2005

  3/3/2006

• Oncolytics Biotech Inc. Reports Highlights And Financial Results For 2005

  3/3/2006

• Oncolytics Biotech Inc. Phase I Combination REOLYSIN(R)/Radiation Clinical Trial Abstract Available On American Association for Cancer Research Website

  3/3/2006

• Oncolytics Biotech Inc. Release: Common Reovirus Purges Cancer Cells From Stem Cell Transplants Following Chemotherapy

  2/21/2006

• Oncolytics Biotech Inc. To Present At Biotechnology Industry Organization (BIO) CEO & Investor Conference

  2/8/2006

• Oncolytics Biotech Inc. Announces Issuance Of 14th U.S. Patent

  2/7/2006

• Oncolytics Biotech Inc. Announces Issuance Of Fourth Canadian Patent

  1/26/2006

• Oncolytics Biotech Inc.'s Research Collaborators To Present Phase I Combination REOLYSIN(R)/Radiation Clinical Trial Data At AACR Conference

  1/24/2006

• Oncolytics Biotech Inc. Announces Commencement Of Solicitation Process For Clinical Trials Sponsored By The U.S. National Cancer Institute

  1/18/2006

• Oncolytics Biotech Inc. Announces Conclusion Of Patient Follow Up In Canadian Phase I Recurrent Malignant Glioma Clinical Trial

  1/17/2006

• Oncolytics Biotech Inc. Announces $16.48 Million Private Placement

  12/13/2005

• Oncolytics Biotech Inc. Release: Reovirus Seeks Out And Destroys Cancer Cells, Preliminary Study Results Show

  12/5/2005

• Oncolytics Biotech Inc. To Webcast Clinical Trial Update For REOLYSIN(R)

  11/14/2005

• Oncolytics Biotech Inc. To Present At The Rodman & Renshaw TechVest 7th Annual Healthcare Conference

  11/3/2005

• Oncolytics Biotech Inc. Announces 2005 Third Quarter Results

  10/26/2005

• Oncolytics Biotech Inc. Announces Issuance Of Third Canadian Patent

  10/20/2005

• Oncolytics Biotech Inc. Provides Final Update On T2 Prostate Cancer Study; Selectively Infects And Kills Tumour Cells

  2/27/2004